Elsevier

Lung Cancer

Volume 146, August 2020, Pages 382-384
Lung Cancer

Novel PNPT1-ALK fusion variant exerted significant benefit to crizotinib in NSCLC

https://doi.org/10.1016/j.lungcan.2020.05.014Get rights and content

Section snippets

Declaration of Competing Interest

None.

Acknowledgements

We thank Mingzhe Xiao, Chuang Qi, Yuan Wu, Lijian Li and Chao Song from Jiangsu Simcere Diagnostics for the kindly assistance. This work was supported by National Natural Science Foundation of China under Grant No. 81800090.

References (5)

There are more references available in the full text version of this article.
1

Linling Jin and Yanli Wang contributed equally to the manuscript.

View full text